China Pharma Holdings
CPHI
5 hedge funds and large institutions have $968K invested in China Pharma Holdings in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more ownership
Funds ownership: 0.01% → 0.02% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
17% less capital invested
Capital invested by funds: $1.17M → $968K (-$205K)
29% less funds holding
Funds holding: 7 → 5 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
+$272K |
| 2 |
Renaissance Technologies
New York
|
+$2.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$19.4K |
| 2 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
-$6.63K |
| 3 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
-$3K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $528K | +$272K | +1,887 | +81% |
|
|
FWSM
2
First Wilshire Securities Management
Pasadena,
California
| $345K | -$6.63K | -46 | -2% |
|
|
GA
3
Glenhill Advisors
New York
| $50K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $39K | +$2.31K | +16 | +5% |
|
|
5
Citadel Advisors
Miami,
Florida
| $6K | -$19.4K | -135 | -74% |
|
|
PFO
6
Pathstone Family Office
Englewood,
New Jersey
| – | -$3K | -17 | Closed |
|
|
U
7
UBS
Zurich,
Switzerland
| – | -$2K | -10 | Closed |
|
CPHI Hedge Fund Activity: Q3 2014 in Review
5 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2014, worth a combined $968K — down 17% from $1.17M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CPHI and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Pope Asset Management, adding an estimated $272K. The largest seller was Citadel Advisors, cutting an estimated $19.4K.
- 5 institutional investors held China Pharma Holdings (CPHI) as of Q3 2014, down from 7 in Q2 2014.
- Funds reported $968K of China Pharma Holdings stock for Q3 2014, down 17% quarter-over-quarter.
- 0 funds opened new China Pharma Holdings positions in Q3 2014 and 2 closed out, a net change of -2 holders.
- The largest China Pharma Holdings buyer in Q3 2014 was Pope Asset Management, an estimated $272K added.
- The largest China Pharma Holdings seller in Q3 2014 was Citadel Advisors, an estimated $19.4K sold.
Based on aggregated 13F filings for Q3 2014.